Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CD22 positive
i
Other names:
CD22, CD22 Molecule, CD22 Antigen, SIGLEC2, Sialic Acid-Binding Ig-Like Lectin 2, B-Lymphocyte Cell Adhesion Molecule, T-Cell Surface Antigen Leu-14, B-Cell Receptor CD22, SIGLEC-2, BL-CAM, Sialic Acid Binding Ig-Like Lectin 2, Siglec-2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
933
Related biomarkers:
Expression
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CD22 positive
B Acute Lymphoblastic Leukemia
CD22 positive
B Acute Lymphoblastic Leukemia
inotuzumab ozogamicin
Sensitive: A1 - Approval
inotuzumab ozogamicin
Sensitive
:
A1
inotuzumab ozogamicin
Sensitive: A1 - Approval
inotuzumab ozogamicin
Sensitive
:
A1
CD22 positive
Lymphoma
CD22 positive
Lymphoma
moxetumomab pasudotox
Sensitive: C2 – Inclusion Criteria
moxetumomab pasudotox
Sensitive
:
C2
moxetumomab pasudotox
Sensitive: C2 – Inclusion Criteria
moxetumomab pasudotox
Sensitive
:
C2
CD22 positive
B Acute Lymphoblastic Leukemia
CD22 positive
B Acute Lymphoblastic Leukemia
blinatumomab + inotuzumab ozogamicin
Sensitive: C2 – Inclusion Criteria
blinatumomab + inotuzumab ozogamicin
Sensitive
:
C2
blinatumomab + inotuzumab ozogamicin
Sensitive: C2 – Inclusion Criteria
blinatumomab + inotuzumab ozogamicin
Sensitive
:
C2
CD22 positive
T Cell Non-Hodgkin Lymphoma
CD22 positive
T Cell Non-Hodgkin Lymphoma
TRPH-222
Sensitive: D – Preclinical
TRPH-222
Sensitive
:
D
TRPH-222
Sensitive: D – Preclinical
TRPH-222
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login